FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame

Hematol Oncol. 2012 Mar;30(1):50-2. doi: 10.1002/hon.998. Epub 2011 May 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage
  • Etoposide / administration & dosage
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Lymphoma / surgery
  • Lymphoma / therapy*
  • Melphalan / administration & dosage
  • Middle Aged
  • Transplantation Conditioning / methods*
  • Transplantation, Homologous / methods
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Cytarabine
  • Etoposide
  • Vidarabine
  • fludarabine
  • Melphalan